GILD DEF 14A DEF-14A Report May 8, 2024 | Alphaminr
GILEAD SCIENCES INC

GILD DEF 14A Report ended May 8, 2024

GILEAD SCIENCES INC
10-Qs and 10-Ks
10-Q
Quarter ended March 31, 2025
10-K
Fiscal year ended Dec. 31, 2024
10-Q
Quarter ended Sept. 30, 2024
10-Q
Quarter ended June 30, 2024
10-Q
Quarter ended March 31, 2024
10-K
Fiscal year ended Dec. 31, 2023
10-Q
Quarter ended Sept. 30, 2023
10-Q
Quarter ended June 30, 2023
10-Q
Quarter ended March 31, 2023
10-K
Fiscal year ended Dec. 31, 2022
10-Q
Quarter ended Sept. 30, 2022
10-Q
Quarter ended June 30, 2022
10-Q
Quarter ended March 31, 2022
10-K
Fiscal year ended Dec. 31, 2021
10-Q
Quarter ended Sept. 30, 2021
10-Q
Quarter ended June 30, 2021
10-Q
Quarter ended March 31, 2021
10-K
Fiscal year ended Dec. 31, 2020
10-Q
Quarter ended Sept. 30, 2020
10-Q
Quarter ended June 30, 2020
10-Q
Quarter ended March 31, 2020
10-K
Fiscal year ended Dec. 31, 2019
10-Q
Quarter ended Sept. 30, 2019
10-Q
Quarter ended June 30, 2019
10-Q
Quarter ended March 31, 2019
10-K
Fiscal year ended Dec. 31, 2018
10-Q
Quarter ended Sept. 30, 2018
10-Q
Quarter ended June 30, 2018
10-Q
Quarter ended March 31, 2018
10-K
Fiscal year ended Dec. 31, 2017
10-Q
Quarter ended Sept. 30, 2017
10-Q
Quarter ended June 30, 2017
10-Q
Quarter ended March 31, 2017
10-K
Fiscal year ended Dec. 31, 2016
10-Q
Quarter ended Sept. 30, 2016
10-Q
Quarter ended June 30, 2016
10-Q
Quarter ended March 31, 2016
10-K
Fiscal year ended Dec. 31, 2015
10-Q
Quarter ended Sept. 30, 2015
10-Q
Quarter ended June 30, 2015
10-Q
Quarter ended March 31, 2015
10-K
Fiscal year ended Dec. 31, 2014
10-Q
Quarter ended Sept. 30, 2014
10-Q
Quarter ended June 30, 2014
10-Q
Quarter ended March 31, 2014
10-K
Fiscal year ended Dec. 31, 2013
10-Q
Quarter ended Sept. 30, 2013
10-Q
Quarter ended June 30, 2013
10-Q
Quarter ended March 31, 2013
10-K
Fiscal year ended Dec. 31, 2012
10-Q
Quarter ended Sept. 30, 2012
10-Q
Quarter ended June 30, 2012
10-Q
Quarter ended March 31, 2012
10-K
Fiscal year ended Dec. 31, 2011
10-Q
Quarter ended Sept. 30, 2011
10-Q
Quarter ended June 30, 2011
10-Q
Quarter ended March 31, 2011
10-K
Fiscal year ended Dec. 31, 2010
10-Q
Quarter ended Sept. 30, 2010
10-Q
Quarter ended June 30, 2010
10-Q
Quarter ended March 31, 2010
10-K
Fiscal year ended Dec. 31, 2009
PROXIES
DEF 14A
Filed on March 27, 2025
DEF 14A
Filed on March 28, 2024
DEF 14A
Filed on March 23, 2023
DEF 14A
Filed on March 24, 2022
DEF 14A
Filed on March 30, 2021
DEF 14A
Filed on March 24, 2020
DEF 14A
Filed on March 25, 2019
DEF 14A
Filed on March 26, 2018
DEF 14A
Filed on March 27, 2017
DEF 14A
Filed on March 28, 2016
DEF 14A
Filed on March 27, 2015
DEF 14A
Filed on March 24, 2014
DEF 14A
Filed on March 19, 2013
DEF 14A
Filed on March 20, 2012
DEF 14A
Filed on March 22, 2011
DEF 14A
Filed on March 22, 2010
TABLE OF CONTENTS
Overview2023 Business HighlightsprintCorporate ResponsibilityprintProxy Voting RoadmapElements of Executive CompensationprintCorporate GovernanceProposal 1: Election of DirectorsThe Gilead Board of DirectorsprintOur Boards Role and ResponsibilitiesprintBoard Leadership StructureprintCommittees of Our Board of DirectorsprintBoard ProcessesprintCompensation of Non-Employee Board MembersprintAudit MattersProposal 2: Ratification of the Selection of Independent Registered Public Accounting FirmAnnual Evaluation and Selection of Independent AuditorprintRotation of Lead Audit PartnerprintPrincipal Accountant Fees and ServicesprintPre-Approval Policy and ProceduresprintAudit Committee ReportExecutive OfficersExecutive CompensationProposal 3: Advisory Vote to Approve the Compensation of Our Named Executive OfficersCompensation Discussion and AnalysisprintOther Executive Compensation Policies and PracticesprintCompensation and Talent Committee ReportprintSeverance and Change in Control Arrangements with Named Executive OfficersprintCEO Pay RatioprintSummary Compensation Tableprint2023 Grants of Plan-Based Awardsprint2023 Outstanding Equity Awards at Fiscal Year-Endprint2023 Option Exercises and Stock Vestedprint2023 Nonqualified Deferred Compensationprint2023 Potential Payments Upon Involuntary Termination or Change in Control TerminationprintPay Versus PerformanceprintCharter Amendment ProposalProposal 4: Approval of an Amendment to Our Restated Certificate of Incorporation to Reflect New Delaware Law Provisions Regarding Officer ExculpationStockholder ProposalsProposal 5: Stockholder Proposal Requesting that the Board Include One Member from Gileads Non-Management EmployeesProposal 6: Stockholder Proposal Requesting that the Board Issue a Report on Risks of Supporting AbortionProposal 7: Stockholder Proposal Requesting that the Board Adopt a Policy Requiring the Named Executive Officers to Retain a Significant Percentage of Stock Acquired through Equity Pay ProgramsStock Ownership InformationSecurity Ownership of Certain Beneficial Owners and ManagementprintOther InformationHouseholding of Proxy MaterialsprintOther Legal MattersprintQuestions and AnswersDetails for the Gilead Sciences, Inc. 2024 Annual Meeting of Stockholders